Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions
Overview
Affiliations
Diabetic foot ulcer (DFU) frequently leads to non-traumatic amputation and finally even death. However, the mechanism of DFU is not fully understood. Interleukin 25 (IL-25), an alarmin cytokine that responds to tissue injury, has been reported to participate in tissue regeneration and maintaining glucose homeostasis. However, the role of IL-25 in diabetic wound healing remains unknown. Here, we showed that interleukin 17 receptor B (IL-17RB), the functional receptor of IL-25, was significantly inhibited in the wound skin of both diabetic patients with DFU and streptozotocin (STZ)-induced diabetic mice. Topical administration of recombinant IL-25 protein improved angiogenesis and collagen deposition in the wound bed and thus ameliorated delayed diabetic wound healing. IL-25 increased endothelial-specific CD31 expression in diabetic wounds and exogenous IL-25 protected endothelial cells from high glucose-impaired cell migration and tube formation . We further revealed that IL-25-mediated-IL-17RB signaling rescued the downregulation of Wnt/β-catenin pathway both in diabetic mice and in HUVECs and induced the phosphorylation of AKT and ERK 1/2 in HUVECs under high glucose conditions. This study defines a positive regulatory role of IL-25-mediated-IL-17RB signaling in diabetic wound healing and suggests that induction of IL-25-mediated-IL-17RB signaling may be a novel therapeutic strategy for treating poor healing diabetic wounds.
Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43716.
PMID: 39990247 PMC: 11844764. DOI: 10.33137/cpoj.v7i2.43716.
Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43715.
PMID: 39990241 PMC: 11844765. DOI: 10.33137/cpoj.v7i2.43715.
Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers.
Yu X, Wu Z, Zhang N Mol Med. 2024; 30(1):215.
PMID: 39543487 PMC: 11562697. DOI: 10.1186/s10020-024-00955-z.
Chen D, Wu J, Zhang F, Lyu R, You Q, Qian Y EMBO Mol Med. 2024; 16(10):2516-2538.
PMID: 39261649 PMC: 11479266. DOI: 10.1038/s44321-024-00128-9.
Preparation of Luvangetin Nanoemulsions: Antimicrobial Mechanism and Role in Infected Wound Healing.
Chong Y, Yu D, Han R, Li Y, Gu Y, Lu Z Int J Nanomedicine. 2024; 19:5493-5509.
PMID: 38882542 PMC: 11178095. DOI: 10.2147/IJN.S457322.